Applied Genetic Technologies Corporation

NasdaqGM:AGTC 주식 보고서

시가총액: US$12.6m

This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Applied Genetic Technologies 미래 성장

Future 기준 확인 2/6

주요 정보

6.5%

수익 성장률

29.5%

EPS 성장률

Biotechs 수익 성장27.9%
매출 성장률68.0%
향후 자기자본 수익률n/a
애널리스트 커버리지

Low

마지막 업데이트n/a

최근 미래 성장 업데이트

Recent updates

AGTC receives positive feedback from FDA for manufacturing facility

Jul 26

Applied Genetic Technologies proposes stock offering to fund clinical trials

Jul 12

Applied Genetic Tech: A Speculative Biotech With Potential To Turn Corner In 2022

Jan 12

An Assessment Of Applied Genetic Technologies Corporation

Dec 14

Applied Genetic Technologies: Weak Early Clinical Ocular Results Highlight Increased Risk

Jul 15

Is Applied Genetic Technologies (NASDAQ:AGTC) A Risky Investment?

May 21
Is Applied Genetic Technologies (NASDAQ:AGTC) A Risky Investment?

Applied Genetic trades lower after announcing the departure of chief scientific officer

Apr 26

What Is The Ownership Structure Like For Applied Genetic Technologies Corporation (NASDAQ:AGTC)?

Feb 05
What Is The Ownership Structure Like For Applied Genetic Technologies Corporation (NASDAQ:AGTC)?

Is Applied Genetic Technologies (NASDAQ:AGTC) Using Debt In A Risky Way?

Jan 06
Is Applied Genetic Technologies (NASDAQ:AGTC) Using Debt In A Risky Way?

What Type Of Returns Would Applied Genetic Technologies'(NASDAQ:AGTC) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?

Dec 11
What Type Of Returns Would Applied Genetic Technologies'(NASDAQ:AGTC) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?

Interim data on gene therapy for vision loss disorder fails to lift Applied Genetic

Nov 11

수익 및 매출 성장 예측

NasdaqGM:AGTC - 애널리스트의 미래 추정치 및 과거 재무 데이터 (USD Millions )
날짜수익수익잉여 현금 흐름작전 현금평균 애널리스트 수
6/30/202512-100-127-992
6/30/2024N/A-90-110-933
6/30/20230-78-96-875
9/30/20220-70-68-66N/A
6/30/20220-69-68-66N/A
3/31/20221-63-63-61N/A
12/31/20211-63-60-58N/A
9/30/20211-60-56-54N/A
6/30/20211-58-53-51N/A
3/31/2021N/A-60-53-52N/A
12/31/2020N/A-57-50-49N/A
9/30/20202-50-45-44N/A
6/30/20202-46-43-42N/A
3/31/20203-42-37-35N/A
12/31/201924-19-34-34N/A
9/30/201928-15-35-35N/A
6/30/201942-2-24-23N/A
3/31/2019472-23-23N/A
12/31/201829-18-24-23N/A
9/30/201828-19-24-23N/A
6/30/201824-21-33-33N/A
3/31/201827-18-37-36N/A
12/31/201732-11-37-37N/A
9/30/201738-4-35-34N/A
6/30/2017390-32-31N/A
3/31/2017436-29-28N/A
12/31/20164710-31-28N/A
9/30/20164811-32-30N/A
6/30/201647-1N/A71N/A
3/31/201636-12N/A72N/A
12/31/201524-20N/A75N/A

애널리스트 미래 성장 예측

수입 대 저축률: AGTC is forecast to remain unprofitable over the next 3 years.

수익 vs 시장: AGTC is forecast to remain unprofitable over the next 3 years.

고성장 수익: AGTC is forecast to remain unprofitable over the next 3 years.

수익 대 시장: AGTC's revenue (68% per year) is forecast to grow faster than the US market (7% per year).

고성장 수익: AGTC's revenue (68% per year) is forecast to grow faster than 20% per year.


주당 순이익 성장 예측


미래 자기자본 수익률

미래 ROE: Insufficient data to determine if AGTC's Return on Equity is forecast to be high in 3 years time


성장 기업 발견